JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 17, 2007; DOI: 10.1124/jpet.107.128017


0022-3565/07/3232-636-649$20.00
JPET 323:636-649, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.128017v1
323/2/636    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pereira, G. C.
Right arrow Articles by Oliveira, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pereira, G. C.
Right arrow Articles by Oliveira, P. J.

TOXICOLOGY

Mitochondrially Targeted Effects of Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 Mouse Melanoma Cells: Comparison with Direct Effects on Isolated Mitochondrial Fractions

Gonçalo C. Pereira, Ana F. Branco, Júlio A. C. Matos, Sandro L. Pereira, Donna Parke, Edward L. Perkins, Teresa L. Serafim, Vilma A. Sardão, Maria S. Santos, Antonio J. M. Moreno, Jon Holy, and Paulo J. Oliveira

Center for Neurosciences and Cell Biology (G.C.P., A.F.B., J.A.C.M., S.L.P., T.L.S., V.A.S., M.S.S., P.J.O.) and Institute for Marine Research (A.J.M.M.), Department of Zoology, University of Coimbra, Coimbra, Portugal; and Departments of Biochemistry and Molecular Biology (D.P., E.L.P.) and Anatomy, Microbiology and Pathology (J.H.), University of Minnesota Medical School, Duluth, Minnesota

Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium] is an alkaloid present in plant extracts and has a history of use in traditional Chinese and Native American medicine. Because of its ability to arrest the cell cycle and cause apoptosis of several malignant cell lines, it has received attention as a potential anticancer therapeutic agent. Previous studies suggest that mitochondria may be an important target of berberine, but relatively little is known about the extent or molecular mechanisms of berberine-mitochondrial interactions. The objective of the present work was to investigate the interaction of berberine with mitochondria, both in situ and in isolated mitochondrial fractions. The data show that berberine is selectively accumulated by mitochondria, which is accompanied by arrest of cell proliferation, mitochondrial fragmentation and depolarization, oxidative stress, and a decrease in ATP levels. Electron microscopy of berberine-treated cells shows a reduction in mitochondria-like structures, accompanied by a decrease in mitochondrial DNA copy number. Isolated mitochondrial fractions treated with berberine had slower mitochondrial respiration, especially when complex I substrates were used, and increased complex I-dependent oxidative stress. It is also demonstrated for the first time that berberine stimulates the mitochondrial permeability transition. Direct effects on ATPase activity were not detected. The present work demonstrates a number of previously unknown alterations of mitochondrial physiology induced by berberine, a potential chemotherapeutic agent, although it also suggests that high doses of berberine should not be used without a proper toxicology assessment.


Received July 10, 2007; accepted August 16, 2007.

Address correspondence to: Dr. Paulo J. Oliveira, Center for Neurosciences and Cell Biology, Department of Zoology, University of Coimbra, P-3004-517 Coimbra, Portugal. E-mail: pauloliv{at}ci.uc.pt




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. W. Jeong, K. C. Hsu, J.-W. Lee, M. Ham, J. Y. Huh, H. J. Shin, W. S. Kim, and J. B. Kim
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E955 - E964.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. V. Pereira, N. G. Machado, and P. J. Oliveira
Mechanisms of Berberine (Natural Yellow 18)-Induced Mitochondrial Dysfunction: Interaction with the Adenine Nucleotide Translocator
Toxicol. Sci., October 1, 2008; 105(2): 408 - 417.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.